
Trump doesn’t have a clue about healthcare
In a press briefing Monday morning, President Donald Trump said, according to multiple news outlets, that, "Nobody knew that healthcare could be so complicated."
In a press briefing Monday morning, President Donald Trump said, according to multiple news outlets, that, "Nobody knew that healthcare could be so complicated."
If and when rates rise again, the cost of debt service will be competing with healthcare and a couple other major components of the federal budget for ever scarcer dollars, Leavitt explained at HIMSS17 this week.
In a statement, Grassley said the inquiry is “based on reporting from Kaiser Health News” and strong consumer concern about high drug prices.
The new rules are set to go into effect in July, but they may be delayed as President Donald Trump’s administration reviews regulations that have been drafted or finalized but not yet implemented.
Sen. Mike Lee (R-Utah) one of the leading conservative voices in that chamber, said he will vigorously oppose efforts for Republicans to wait until they have a plan ready to replace the law before they repeal it.
Craig Holman, government affairs lobbyist with Public Citizen, described Price’s volume of stock trades during the SEC inquiry as “brazen,” given the congressman’s access to nonpublic information affecting the companies’ fortunes.
There's long been an unwritten rule in Washington: Don't piss off seniors, because they vote in higher percentages than younger demographics.
Senate Finance Committee Chairman Sen. Orrin Hatch (R-Utah) suspended rules requiring a quorum for a vote, allowing Price to advance to the full Senate.
Actor/comedian Colton Dunn, of "Superstore" on NBC, has picked up the slack, posting a series of low-budget but effective videos as alternative ads for HealthCare.gov.
@AltHHS describes itself as "Unofficial and unaffiliated resistance account by concerned scientists for humanity."
Senate Finance Committee ranking member Ron Wyden (D-Oregon) was rather relentless in questioning Price.
At least six members of the two Senate committees tasked with questioning or confirming Tom Price for HHS secretary hold shares in healthcare companies — such as Merck, Medtronic and Gilead — according to a Kaiser Health News analysis.
The PAC was operated by Georgia-based MiMedx, whose CEO Parker H. “Pete” Petit is among the top individual contributors to Price. Federal election law prohibits corporations from coercing employees to contribute to PACs.
Price told HHS ethics officials Thursday that if appointed to be HHS secretary, he will divest himself of the Australian stock as well as stock in about 40 other companies that could pose conflicts.
Several recent developments are of note as consumer electronics companies, hearing aid manufacturers, audiologists, physicians, consumer advocates and regulators prepare for a surge of new hearing devices and changes in the hearing healthcare system.